Review Article| Volume 34, ISSUE 3, P613-621, September 2014

Four-Factor Prothrombin Complex Concentrate Versus Plasma for Urgent Vitamin K Antagonist Reversal

New Evidence


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. IMS data US national prescription audit; MAT (moving annual total) 2011–2012. Avaiable at:

        • Gomes T.
        • Mamdani M.M.
        • Holbrook A.M.
        • et al.
        Rates of hemorrhage during warfarin therapy for atrial fibrillation.
        CMAJ. 2013; 185: E121-E127
        • Budnitz D.S.
        • Lovegrove M.C.
        • Shehab N.
        • et al.
        Emergency hospitalizations for adverse drug events in older Americans.
        N Engl J Med. 2011; 365: 2002-2012
        • Shehab N.
        • Sperling L.S.
        • Kegler S.R.
        • et al.
        National estimates of emergency department visits for hemorrhage-related adverse events from clopidogrel plus aspirin and from warfarin.
        Arch Intern Med. 2010; 170: 1926-1933
        • Wysowski D.K.
        • Nourjah P.
        • Swartz L.
        Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action.
        Arch Intern Med. 2007; 167: 1414-1419
        • Goldstein J.N.
        • Thomas S.H.
        • Frontiero V.
        • et al.
        Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage.
        Stroke. 2006; 37: 151-155
        • Aguilar M.I.
        • Hart R.G.
        • Kase C.S.
        • et al.
        Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion.
        Mayo Clin Proc. 2007; 82: 82-92
        • Hirsh J.
        • Fuster V.
        • Ansell J.
        • et al.
        American Heart Association/American College of Cardiology Foundation guide to warfarin therapy.
        Circulation. 2003; 107: 1692-1711
        • Keeling D.
        • Baglin T.
        • Tait C.
        • et al.
        Guidelines on oral anticoagulation with warfarin—fourth edition.
        Br J Haematol. 2011; 154: 311-324
        • Holbrook A.
        • Schulman S.
        • Witt D.M.
        • et al.
        Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines.
        Chest. 2012; 141: e152S-e184S
        • Pernod G.
        • Godier A.
        • Gozalo C.
        • et al.
        French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding).
        Thromb Res. 2010; 126: e167-e174
        • Levy J.H.
        • Tanaka K.A.
        • Dietrich W.
        Perioperative hemostatic management of patients treated with vitamin K antagonists.
        Anesthesiology. 2008; 109: 918-926
        • Ageno W.
        • Gallus A.S.
        • Wittkowsky A.
        • et al.
        Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines.
        Chest. 2012; 141: e44S-e88S
        • Narick C.
        • Triulzi D.J.
        • Yazer M.H.
        Transfusion-associated circulatory overload after plasma transfusion.
        Transfusion. 2012; 52: 160-165
        • Magee G.
        • Zbrozek A.
        Fluid overload is associated with increases in length of stay and hospital costs: pooled analysis of data from more than 600 US hospitals.
        Clinicoecon Outcomes Res. 2013; 5: 289-296
        • Fredriksson K.
        • Norrving B.
        • Stromblad L.G.
        Emergency reversal of anticoagulation after intracerebral hemorrhage.
        Stroke. 1992; 23: 972-977
        • Makris M.
        • Greaves M.
        • Phillips W.S.
        • et al.
        Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy.
        Thromb Haemost. 1997; 77: 477-480
        • Hanley J.P.
        Warfarin reversal.
        J Clin Pathol. 2004; 57: 1132-1139
      2. 4 Plasma for therapeutic use.
        Transfus Med Hemother. 2009; 36: 388-397
        • Kozek-Langenecker S.A.
        • Afshari A.
        • Albaladejo P.
        • et al.
        Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology.
        Eur J Anaesthesiol. 2013; 30: 270-382
        • Spahn D.R.
        • Bouillon B.
        • Cerny V.
        • et al.
        Management of bleeding and coagulopathy following major trauma: an updated European guideline.
        Crit Care. 2013; 17: R76
        • Pabinger I.
        • Brenner B.
        • Kalina U.
        • et al.
        Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial.
        J Thromb Haemost. 2008; 6: 622-631
        • Kalina M.
        • Tinkoff G.
        • Gbadebo A.
        • et al.
        A protocol for the rapid normalization of INR in trauma patients with intracranial hemorrhage on prescribed warfarin therapy.
        Am Surg. 2008; 74: 858-861
        • Khorsand N.
        • Veeger N.J.
        • van Hest R.M.
        • et al.
        An observational, prospective, two-cohort comparison of a fixed versus variable dosing strategy of prothrombin complex concentrate to counteract vitamin K antagonists in 240 bleeding emergencies.
        Haematologica. 2012; 97: 1501-1506
        • Bruce D.
        • Nokes T.J.
        Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital.
        Crit Care. 2008; 12: R105
        • Scott L.J.
        Prothrombin complex concentrate (Beriplex P/N).
        Drugs. 2009; 69: 1977-1984
        • Sarode R.
        • Milling Jr., T.J.
        • Refaai M.A.
        • et al.
        Efficacy and safety of a 4-Factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.
        Circulation. 2013; 128: 1234-1243
        • Hickey M.
        • Gatien M.
        • Taljaard M.
        • et al.
        Outcomes of urgent warfarin reversal with frozen plasma versus prothrombin complex concentrate in the emergency department.
        Circulation. 2013; 128: 360-364
      3. Kcentra US prescribing information. 2013. Available at:

        • Dentali F.
        • Marchesi C.
        • Pierfranceschi M.G.
        • et al.
        Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis.
        Thromb Haemost. 2011; 106: 429-438
        • Pabinger I.
        • Tiede A.
        • Kalina U.
        • et al.
        Impact of infusion speed on the safety and effectiveness of prothrombin complex concentrate: a prospective clinical trial of emergency anticoagulation reversal.
        Ann Hematol. 2010; 89: 309-316
        • Holland L.
        • Warkentin T.E.
        • Refaai M.
        • et al.
        Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose.
        Transfusion. 2009; 49: 1171-1177
        • Guest J.F.
        • Watson H.G.
        • Limaye S.
        Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United Kingdom.
        Clin Ther. 2010; 32: 2478-2493